Conference
Quality of life (QOL) differentiation analysis in patients undergoing controlled ovarian stimulation (COS) with two different preparations of recombinant human follicle-stimulating hormone (r-hFSH)
Authors
Beresniak A; Brasseur P; Daya S; Silverberg K; Wikland M; Duru G; Decostered G; Brasseur P; Blatz S
Volume
6
Pagination
pp. 707-708
Publisher
ELSEVIER SCIENCE INC
Publication Date
November 1, 2003
Conference proceedings
VALUE IN HEALTH
Issue
6
ISSN
1098-3015